<?xml version='1.0' encoding='utf-8'?>
<document id="12410060"><sentence text="Severe weight gain induced by combination treatment with risperidone and paroxetine."><entity charOffset="57-68" id="DDI-PubMed.12410060.s1.e0" text="risperidone" /><entity charOffset="73-83" id="DDI-PubMed.12410060.s1.e1" text="paroxetine" /><pair ddi="false" e1="DDI-PubMed.12410060.s1.e0" e2="DDI-PubMed.12410060.s1.e0" /><pair ddi="false" e1="DDI-PubMed.12410060.s1.e0" e2="DDI-PubMed.12410060.s1.e1" /></sentence><sentence text="Successful combination therapy with atypical antipsychotics and selective serotonin reuptake inhibitors has been reported for several psychiatric conditions"><entity charOffset="74-83" id="DDI-PubMed.12410060.s2.e0" text="serotonin" /></sentence><sentence text=" However, great attention should be paid to the possible adverse effects" /><sentence text=" In this retrospective chart review, we focused on the drug-drug interaction of paroxetine and risperidone"><entity charOffset="80-90" id="DDI-PubMed.12410060.s4.e0" text="paroxetine" /><entity charOffset="95-106" id="DDI-PubMed.12410060.s4.e1" text="risperidone" /><pair ddi="false" e1="DDI-PubMed.12410060.s4.e0" e2="DDI-PubMed.12410060.s4.e0" /><pair ddi="false" e1="DDI-PubMed.12410060.s4.e0" e2="DDI-PubMed.12410060.s4.e1" /></sentence><sentence text=" Retrospectively, we identified two patients treated with a combination of risperidone and paroxetine therapy, and analyzed their medical records"><entity charOffset="75-86" id="DDI-PubMed.12410060.s5.e0" text="risperidone" /><entity charOffset="91-101" id="DDI-PubMed.12410060.s5.e1" text="paroxetine" /><pair ddi="false" e1="DDI-PubMed.12410060.s5.e0" e2="DDI-PubMed.12410060.s5.e0" /><pair ddi="false" e1="DDI-PubMed.12410060.s5.e0" e2="DDI-PubMed.12410060.s5.e1" /></sentence><sentence text=" During a 3-month period of monotherapy with risperidone, the changes in body weight were +/- 0"><entity charOffset="45-56" id="DDI-PubMed.12410060.s6.e0" text="risperidone" /></sentence><sentence text="0 kg in Patient 1 and -2" /><sentence text="0 kg in Patient 2" /><sentence text=" In contrast, during combination therapy with paroxetine and risperidone, the body-weight changes were +14"><entity charOffset="46-56" id="DDI-PubMed.12410060.s9.e0" text="paroxetine" /><entity charOffset="61-72" id="DDI-PubMed.12410060.s9.e1" text="risperidone" /><pair ddi="false" e1="DDI-PubMed.12410060.s9.e0" e2="DDI-PubMed.12410060.s9.e0" /><pair ddi="false" e1="DDI-PubMed.12410060.s9.e0" e2="DDI-PubMed.12410060.s9.e1" /></sentence><sentence text="0 kg in Patient 1 (after 4 months) and +13" /><sentence text="5 kg in Patient 2 (after 5 months)" /><sentence text=" In addition, diabetes mellitus was observed in Patient 2" /><sentence text=" Regarding the mechanism of severe weight gain in these two patients, we speculate a drug-drug interaction involving inhibition of the cytochrome P450 enzyme 2D6 (CYP4502D6) by paroxetine"><entity charOffset="177-187" id="DDI-PubMed.12410060.s13.e0" text="paroxetine" /></sentence><sentence text="" /></document>